391 related articles for article (PubMed ID: 34261404)
1. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
Pan X; Liu JH
Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
[TBL] [Abstract][Full Text] [Related]
2. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
6. Identification of key pathways and genes in nasopharyngeal carcinoma based on WGCNA.
Dai Y; Chen W; Huang J; Xie L; Lin J; Chen Q; Jiang G; Huang C
Auris Nasus Larynx; 2023 Feb; 50(1):126-133. PubMed ID: 35659152
[TBL] [Abstract][Full Text] [Related]
7. Screening of core genes and prediction of ceRNA regulation mechanism of circRNAs in nasopharyngeal carcinoma by bioinformatics analysis.
Chen H; Shi X; Ren L; Wan Y; Zhuo H; Zeng L; SangDan W; Wang F
Pathol Oncol Res; 2023; 29():1610960. PubMed ID: 37056700
[No Abstract] [Full Text] [Related]
8. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
9. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
11. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells.
Zhu K; Ge J; He Y; Li P; Jiang X; Wang J; Mo Y; Huang W; Gong Z; Zeng Z; Xiong W; Yu J
DNA Cell Biol; 2021 Aug; 40(8):1052-1063. PubMed ID: 34191589
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
Wu ZH; Zhou T; Sun HY
Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
Zhang JZ; Wu ZH; Cheng Q
Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.
Zhou W; Chang A; Zhao H; Ye H; Li D; Zhuo X
Cancer Biomark; 2020; 27(4):533-539. PubMed ID: 32083569
[TBL] [Abstract][Full Text] [Related]
18. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
19. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]